LayerBio, Inc Information

LayerBio is a clinical-stage biotechnology company developing sustained-release drug delivery solutions for ophthalmology. Its proprietary OcuRing™ platform is designed to enable precise, localized delivery of therapeutics within the eye, improving efficacy, safety, and durability while reducing reliance on patient-administered eye drops. The company’s lead program, OcuRing-K™, is an intraocular implant delivering sustained levels of ketorolac for patients undergoing cataract surgery. LayerBio’s approach aims to address key limitations of conventional therapies and improve compliance, clinical outcomes, and overall patient experience.